ABOUT ELITE
PRODUCTS
PIPELINE
- Generic
- Branded
TECHNOLOGY
INVESTOR RELATIONS

HOME | CAREERS | CONTACT | NEWS |

Skip to content

About Elite
Products
Pipeline
- Generic
- Branded
Technology
Investor Relations

Press Releases

Select:

Jun 11, 2015 Elite Pharmaceuticals, Inc. to Host Conference Call and Webcast to Discuss Year End 2015 Financial Results on June 16, 2015

Jun 09, 2015 Elite Pharmaceuticals and Epic Pharma Enter Into a Sales and Distribution Licensing Agreement for Abuse-Deterrent ELI-200

Apr 21, 2015 Elite Pharmaceuticals Announces Launch of Generic Hydroxyzine Tablets

Feb 17, 2015 Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2015

Feb 17, 2015 Elite Pharmaceuticals Provides Guidance on Phase III Study for ELI-200

Feb 12, 2015 Elite Pharmaceuticals, Inc. to Host Quarterly Business Update Call on Wednesday, February 18, 2015

Jan 15, 2015 Elite Pharmaceuticals Announces First Shipment of Generic Isradipine Capsules

Dec 16, 2014 Elite Pharmaceuticals Awarded Second Canadian Patent for Abuse Deterrent Drug Formulation

Nov 14, 2014 Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2015

Sep 09, 2014 Elite Pharmaceuticals Releases Positive Top Line Human Abuse Liability Data For Eli-200, An Opioid Abuse Deterrent Product

12 13 14 15 16 17 18 19 20 21 22

<< < > >>

Site Map | Privacy | Terms Of Use

Copyright © Elite Pharmaceuticals Inc. | All Rights Reserved.

ART™: Abuse-Resistant Technology for a safer healthier you.

Resize Viewer - Reduce

Resize Viewer - Expand